Tau Positron Emission Tomography (PET) Imaging in the Northern Manhattan Study of Metabolism and Mind (NOMEM) With 18F-MK6240.
Phase of Trial: Phase II
Latest Information Update: 20 Mar 2018
At a glance
- Drugs Fluorine-18-MK 6240 (Primary)
- Indications Neurodegenerative disorders
- Focus Diagnostic use
- Acronyms NOMEM-Tau
- 15 Mar 2018 Status changed from not yet recruiting to recruiting.
- 05 Jan 2018 New trial record